Anna Estival

911 total citations
37 papers, 316 citations indexed

About

Anna Estival is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Anna Estival has authored 37 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 14 papers in Genetics. Recurrent topics in Anna Estival's work include Glioma Diagnosis and Treatment (14 papers), Brain Metastases and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Anna Estival is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Brain Metastases and Treatment (9 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Anna Estival collaborates with scholars based in Spain, Netherlands and United Kingdom. Anna Estival's co-authors include Carmen Balañá, Enriqueta Felip, Marta Simó, Ivana Sullivan, Ernest Nadal, Ana Blasco, Jordi Bruna, Bartomeu Massutí, M. Guirado and Federico Longo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Anna Estival

29 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Estival Spain	12	174	161	66	63	49	37	316
Jörn Rüssel Germany	8	123 0.7×	142 0.9×	46 0.7×	49 0.8×	37 0.8×	21	317
María Ángeles Vaz Salgado Spain	9	101 0.6×	125 0.8×	122 1.8×	81 1.3×	28 0.6×	44	354
Nausicaa Malissen France	10	131 0.8×	197 1.2×	32 0.5×	75 1.2×	33 0.7×	26	353
A. Valent France	10	125 0.7×	155 1.0×	33 0.5×	101 1.6×	52 1.1×	18	318
Erin Twohy United States	9	138 0.8×	141 0.9×	121 1.8×	75 1.2×	46 0.9×	18	385
Nelly Firmin France	11	237 1.4×	235 1.5×	63 1.0×	93 1.5×	84 1.7×	51	446
Takuma Oishi Japan	13	163 0.9×	201 1.2×	94 1.4×	49 0.8×	83 1.7×	47	417
Sarah Péricart France	11	79 0.5×	155 1.0×	49 0.7×	82 1.3×	125 2.6×	24	335
Manuel Magerle Austria	8	275 1.6×	244 1.5×	136 2.1×	147 2.3×	46 0.9×	9	438
Wolfgang Tränkenschuh Germany	11	81 0.5×	113 0.7×	56 0.8×	140 2.2×	131 2.7×	18	348

Countries citing papers authored by Anna Estival

Since Specialization

Citations

This map shows the geographic impact of Anna Estival's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Estival with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Estival more than expected).

Fields of papers citing papers by Anna Estival

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Estival. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Estival. The network helps show where Anna Estival may publish in the future.

Co-authorship network of co-authors of Anna Estival

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Estival. A scholar is included among the top collaborators of Anna Estival based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Estival. Anna Estival is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carrió, Meritxell, Bernat Gel, Alberto Villanueva, et al.. (2025). New models for MPNST: establishment and comprehensive characterization of two tumor cell lines. Cancer Cell International. 25(1). 268–268.

Kim, Dong‐Wan, Byoung Chul Cho, Sang‐We Kim, et al.. (2024). Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study. Lung Cancer. 190. 107530–107530. 5 indexed citations

Candal‐Pedreira, Cristina, Alberto Ruano‐Raviña, Virginia Calvo, et al.. (2024). Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry. Archivos de Bronconeumología. 60. S38–S45. 1 indexed citations

Fernández‐Rodríguez, Juana, Cleofé Romagosa, Anna Estival, et al.. (2023). Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities. Molecular Oncology. 18(4). 895–917. 2 indexed citations

Cucurull, Marc, Montse Sánchez‐Céspedes, Cinta Hierro, et al.. (2022). Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies. Frontiers in Oncology. 11. 793121–793121. 21 indexed citations

Estival, Anna, et al.. (2022). Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time. Clinical & Translational Oncology. 24(12). 2475–2479.

Schöffski, Patrick, Maud Toulmonde, Anna Estival, et al.. (2021). Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG “ANITA”. European Journal of Cancer. 152. 26–40. 10 indexed citations

Fernández‐Rodríguez, Juana, Ernest Terribas, Cleofé Romagosa, et al.. (2021). Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor initiation. Human Genetics. 140(8). 1241–1252. 12 indexed citations

Nadal, Ernest, Bartomeu Massutí, Rafael López Castro, et al.. (2021). OA09.02 Atezo-Brain: Single Arm Phase II Study of Atezolizumab Plus Chemotherapy in Stage IV NSCLC With Untreated Brain Metastases. Journal of Thoracic Oncology. 16(10). S863–S863. 13 indexed citations

10.

Cirauqui, Beatriz, Teresa Morán, Anna Estival, et al.. (2020). Breast Cancer Patient with Li-Fraumeni Syndrome: A Case Report Highlighting the Importance of Multidisciplinary Management. Case Reports in Oncology. 13(1). 130–138. 2 indexed citations

11.

Reck, Martin, Kathryn F. Mileham, D.A. Clump, et al.. (2020). 1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC). Annals of Oncology. 31. S897–S898. 2 indexed citations

12.

Mesa, Joaquı́n Molero, Carmen Balañá, Anna Estival, et al.. (2020). Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns. Clinical & Translational Oncology. 23(3). 554–564. 18 indexed citations

13.

Lucente, Giuseppe, Laura Vidal, Enric Carcereny, et al.. (2019). Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab. Clinical & Translational Oncology. 22(3). 411–419.

14.

Estival, Anna, Carolina Sanz, José Luis Ramírez, et al.. (2019). Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients. Scientific Reports. 9(1). 11125–11125. 28 indexed citations

15.

Losa, Ferrán, G. Soler, Antonio Casado, et al.. (2017). SEOM clinical guideline on unknown primary cancer (2017). Clinical & Translational Oncology. 20(1). 89–96. 41 indexed citations

16.

Poveda, Andrés, Virginia Martínez, César Serrano, et al.. (2016). SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016). Clinical & Translational Oncology. 18(12). 1221–1228. 16 indexed citations

17.

Estival, Anna, Estela Pineda, Maria Martinez‐García, et al.. (2016). MGMT methylated (Met) patients (p) with glioblastoma (GBM) have a better prognosis with an earlier response (ER) than those who have a late response or pseudoprogression (LR/PsP). Results of the Gliocat study. Annals of Oncology. 27. vi107–vi107. 1 indexed citations

18.

Teixidor, Pilar, Gerard Plans, Santiago Medrano, et al.. (2016). Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines. Clinical & Translational Oncology. 19(6). 727–734. 7 indexed citations

19.

Martinez‐García, Maria, Estela Pineda, Sonia Del Barco, et al.. (2016). Feasibility and efficacy of concomitant chemoradiation (Ch-RT) in the management of newly diagnosed elderly glioblastoma (GB) patients: Results from the GLIOCAT study.. Journal of Clinical Oncology. 34(15_suppl). 2045–2045.

20.

Estival, Anna, et al.. (1984). [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].. PubMed. 8(10). 736–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact